# OnCo record nct04421820 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04421820/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04421820", "NCT04421820" ;
  schema:name "BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours"@en ;
  schema:description "A phase 1/2 trial of Leucovorin, FLOT, Fluorouracil in colorectal cancer, run by Bold Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04421820/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04421820> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2020-08-28" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/leucovorin/>, <https://onco.cc/drugs/flot/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/capox/> .